WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intellia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Birgit C. SchultesEVP Chief Scientific Officer2026-01-058,508$9.21
$78.36kSell
James BastaEVP General Counsel2026-01-0510,397$9.21
$95.76kSell
Eliana ClarkEVP Chief Technical Officer2026-01-059,515$9.21
$87.63kSell
Fred E. CohenDirector2026-01-05150,000$9.35
$1.40MBuy
Michael P. DubeVP Chief Accounting Officer2026-01-052,989$9.21
$27.53kSell
Edward J. Dulac IiiEVP Chief Financial Officer2026-01-056,379$9.21
$58.75kSell
David LebwohlEVP Chief Medical Officer2026-01-0511,903$9.21
$109.63kSell
John M. LeonardPresident and CEO2026-01-0534,146$9.21
$314.48kSell
John M. LeonardPresident and CEO2025-12-128,557$6.83
$58.44kBuy
John M. LeonardPresident and CEO2025-12-115,355$9.59
$51.35kSell

1 of 3

NTLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NTLA insiders and whales buy or sell their stock.

NTLA Shareholders

What type of owners hold Intellia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC10.29%11,919,178$143.03MInstitution
Vanguard Group Inc9.54%11,044,820$132.54MInstitution
Blackrock Inc8.01%9,275,817$111.31MInstitution
Morgan Stanley5.20%6,022,576$72.27MInstitution
Contrarius Group Holdings Ltd5.08%5,889,936$70.68MInstitution
Rachel E. Haurwitz4.83%5,593,846$67.13MInsider
Caribou Therapeutics Holdco LLC4.83%5,593,846$67.13MInsider
State Street Corp4.29%4,970,869$59.65MInstitution
Novartis Institutes For Biomedical Research Inc3.76%4,352,295$52.23MInsider
Goldman Sachs Group Inc3.69%4,278,677$51.34MInstitution

1 of 3

NTLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NTLA72.71%27.29%Net BuyingNet Buying
RAPP75.35%24.65%Net SellingNet Selling
NVAX63.50%17.16%Net SellingNet Selling
ATAI12.02%25.40%Net Buying
QURE88.87%11.08%Net SellingNet Selling
View Top Biotech Stocks

Intellia Therapeutics Stock Ownership FAQ

Who owns Intellia Therapeutics?

Intellia Therapeutics (NASDAQ: NTLA) is owned by 89.93% institutional shareholders, 33.76% Intellia Therapeutics insiders, and 0.00% retail investors. Rachel E. Haurwitz is the largest individual Intellia Therapeutics shareholder, owning 5.59M shares representing 4.83% of the company. Rachel E. Haurwitz's Intellia Therapeutics shares are currently valued at $65.00M.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.